Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.08 per share in line with the Zack

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst

PLGO, BLPD, INN, RFIL and MBOT have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 20

HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since comme

As momentum continues to rise in the U.S., reflected in increased accounts and usage across several

HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Leading academic center with multi-hospital and multi-state health system deepens Company's footprin

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

HINGHAM, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) wi

HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearanc

Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure migh

Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript

Microbot to Hold Conference Call to Review Recent Progress; Executive Team to be Joined by Current L

https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-

Recent transition to the Full Market Release has already resulted in increased revenue for the curre

Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.05 per share versus the Zacks Cons

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as

Commencement of activities in international markets is supported by the successful completion of the

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and c

Members of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional R

MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boostin

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with

To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their n

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst

Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on beni

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead

International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advan

Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a

Gainers

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after p

  On Wednesday, 345 companies set new 52-week lows.